iAnthus Capital Holdings (IAN-CSE)

BUY

Comparable to Medmen Enterprises. American-based sales of legal cannabis, with operations in six states, including the 48 million people of Massachusetts, Florida and New York. They have one of the 10 licenses in New York and one of the 13 in Florida. This is one of her largest holdings. Â There have been several catalysts recently in the United States. For example New York state’s Department of Health recommended that anyone with an opioid addiction be allowed to access cannabis as an alternative, and generally recommended legalization of recreational cannabis. The opioid crisis affects 4% of the US population, so this presents a large opportunity for cannabis sellers. This company locates is dispensaries in prime areas.

Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

iAnthus Capital Holdings (IAN-CSE) Frequently Asked Questions

What is iAnthus Capital Holdings stock symbol?

iAnthus Capital Holdings is a OTC stock, trading under the symbol IAN-CSE on the undefined (undefined). It is usually referred to as or IAN-CSE

Is iAnthus Capital Holdings a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on IAN-CSE on Stockchase. Read the latest expert commentary for iAnthus Capital Holdings .

Is iAnthus Capital Holdings a good investment or a top pick?

iAnthus Capital Holdings was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for iAnthus Capital Holdings .

Why is iAnthus Capital Holdings stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for iAnthus Capital Holdings .

Is iAnthus Capital Holdings worth watching?

iAnthus Capital Holdings is covered by Stockchase experts and is worth watching.